Cleared Special

K130784 - SPIROTEL

K130784 is an FDA 510(k) clearance for SPIROTEL, manufactured by Mir Medical Intl. Research Srl. The device is a Class 2 Anesthesiology device with product code BZG cleared through the Special 510(k) pathway after a 223-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
223d
Days
Class 2
Risk

K130784 is an FDA 510(k) clearance for the SPIROTEL. Classified as Spirometer, Diagnostic (product code BZG), Class II - Special Controls.

Submitted by Mir Medical Intl. Research Srl (Roma, IT). The FDA issued a Cleared decision on October 30, 2013 after a review of 223 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1840 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K130784

510(k) Number K130784 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 21, 2013
Decision Date October 30, 2013
Days to Decision 223 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d slower than avg
Panel avg: 140d · This submission: 223d
Pathway characteristics
Modification to existing cleared device.

BZG Device Classification - Class 2, Special Controls

Product Code BZG Spirometer, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZG Spirometer, Diagnostic

All 158
Devices cleared under the same product code (BZG) and FDA review panel - the closest regulatory comparables to K130784.
MEDIKRO NANO, MEDIKRO PRIMO AND MEDIKRO PRO
K133428 · Medikro OY · May 2014
ASTHMA MONITOR AM3
K133722 · Eresearch Technology · May 2014
SPM-300
K130322 · Bionet Co., Ltd. · Nov 2013
CCS-200 SPIROMETER
K123896 · Benson Medical Instruments Co. · Sep 2013
MINISPIR
K122384 · Mir Medical Intl. Research Srl · Oct 2012
ORBIT
K120880 · National Biomedical, LLC Dba Qrs Diagnostic · Apr 2012